Genotek is a Russian company based in Moscow, founded in 2011, providing DNA testing services for both B2B (clinics, research institutes, medical institutions) and B2C segments. The company offers a range of genetic testing services including predisposition to diseases, drug reactions, lineage tracing, planning for future children, beauty genetics, and personal traits. The company's core value lies in its team, composed of top graduates from leading Russian and international universities specializing in bioinformatics, genetics, economics, and finance. Genotek has garnered a $4.00M corporate round investment from Yandex on 24 December 2020. The company collaborates with esteemed institutions such as the Vavilov Institute of General Genetics of the Russian Academy of Sciences, the Institute of Cytology and Genetics of the Russian Academy of Sciences, the Moscow Research Institute of Pediatrics and Pediatric Surgery, and the Scientific Center for Family Health and Human Reproduction Problems of the Siberian Branch of the Russian Academy of Medical Sciences. Genotek's services provide lifelong access to valuable genetic information through a single DNA test. Operating in the Health Care and Clean Energy industries, the company's pioneering work in making genetic research widely accessible positions it as a promising player in the biotechnology sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | $4.00M | 1 | Yandex | 24 Dec 2020 |
Seed Round | $1.00M | 1 | Pharmstandard | 17 Feb 2017 |
Angel Round | $2.00M | 2 | Maxim Basov, Konstantin Stiskin | 09 Feb 2016 |